Coverage may depend on BMI, weight-related conditions and whether the plan includes anti-obesity medications
Semaglutide, while effective, has a higher risk profile including nausea, vomiting, pancreatitis, and a black box warning for thyroid tumors
Currently, this product is available in the following states: AK, AZ, CO, CT, DE, FL, GA, HI, ID, IL, IA, KS, KY, LA, ME, MD, MA, MI, MN, MO, MT, NE, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SD, TN, TX, UT, VT, VA, WA, WI, and WY
GLP-1 therapies can benefit all of these factors, helping with weight loss, improving blood sugar control, lowering blood pressure, improving cholesterol profiles and reducing inflammation all at the same time
In one particular study, 957 participants were involved, all of whom had a BMI of 30 or higher, were over 18 years old, and were non-diabetic
Novo Nordisks recent data shows that the company is able to keep up with supply and demand requirements